STOCK TITAN

AI/ML Innovations Inc - AIMLF STOCK NEWS

Welcome to our dedicated news page for AI/ML Innovations (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI/ML Innovations.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AI/ML Innovations's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AI/ML Innovations's position in the market.

Rhea-AI Summary
AI/ML Innovations Inc. reports an update on the 'Electronic Patient Reported Biometric Measures' (ePReBMs) clinical study, a collaborative initiative with the University of Alberta's Faculty of Medicine & Dentistry. The project leverages Health Gauge's Phoenix wrist wearable to collect vital biometrics and address the burden of respiratory diseases in modern healthcare. Recruitment for the project began in Q4 2023 and is expected to reach its participant goal by June 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
-
Rhea-AI Summary
AI/ML Innovations Inc. announces the launch of 'The Pulse Whisperer' by its subsidiary, Health Gauge Inc., a product suite that provides Life Science Researchers with unprecedented access to raw biometric signals from smart sensor wearables. The suite includes Health Gauge's Smart Sensor Wearables, Device Firmware, SDK & APIs, and licensed access to Health Gauge's Proprietary and Patented Neural Network technology, enabling researchers to harness rich, previously inaccessible data. The product aims to revolutionize health research and is expected to be adopted by various sectors including medical research, education, healthcare technology development, data science, pharmaceutical companies, and government health policy makers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary
Health Gauge Inc., a majority-owned subsidiary of AI/ML Innovations Inc., has announced the launch of a pilot program in collaboration with Cornerstone Physiotherapy to provide Canada's first remote Program for Long Covid Rehabilitation. The initiative aims to leverage smart sensor wearables and the Health Gauge Biometrics Platform for Life Sciences, impacting remote healthcare with scalable biometrics technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
partnership covid-19 AI
Rhea-AI Summary
AI/ML Innovations Inc. has announced a Shares for Debt Transaction agreement with Octagon Media Inc. The company will issue 1,131,134 Common Shares at a deemed price of $0.065 per share to settle a debt of USD $55,000 (CDN $73,523.72). The transaction is subject to the approval of the Canadian Securities Exchange and the Common Shares will be subject to a four-month hold period.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
AI
-
Rhea-AI Summary
AI/ML Innovations Inc. (AIML) to Hold Live Townhall Event with CEO Paul Duffy on January 11th
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
AI
-
Rhea-AI Summary
AI/ML Innovations Inc. (AIML) closed a non-brokered private placement financing of $754,599.94, issuing units at $0.06 per unit, each consisting of a common share and a common share warrant. The Warrants have a term of two years, entitling the holder to purchase one Warrant Share at $0.12 per share. The Common Shares and Warrants are subject to a hold period until April 16, 2024. The Company intends to use the proceeds for working capital requirements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
AI
Rhea-AI Summary
AI/ML Innovations Inc. (AIML) terminates Marketing Services Agreement with Octagon Media Corp and Jack Marks. CEO Paul Duffy announces arms-length funding, propelling the company into a new phase of strategic development. The company achieves all stated milestones in the First 100-Day plan and plans to share the Next 100-Day plan in early January.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
AI
-
Rhea-AI Summary
AI/ML Innovations Inc. (AIML) has appointed Follow The Money Investment Group (FTMIG) as a marketing consultant to increase awareness of the company through various market communications initiatives. FTMIG will be paid $75,200 plus direct expenses from general corporate funds for a 12-month period.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary
AI/ML Innovations Inc. (AIML) plans to close a non-brokered private placement, accepting subscriptions for 11,576,666 units at $0.06 per unit, resulting in gross proceeds of $694,599.94. Each unit consists of one common share and one common share warrant, with the intention to use the net proceeds for working capital requirements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.76%
Tags
AI
Rhea-AI Summary
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) issues 1,400,000 stock options to management and consultants at $0.20 per share, with exercise periods of up to 5 years for management and 2 years for consultants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
AI/ML Innovations Inc

OTC:AIMLF

AIMLF Rankings

AIMLF Stock Data

4.77M
70.28M
6.84%
Gold Ore Mining
Mining, Quarrying, and Oil and Gas Extraction
Link
Canada
Toronto